| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/23/2009 | US7550442 For therapy of subject infected with a retrovirus |
| 06/23/2009 | CA2522220C Cgrp receptor antagonists |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2300148C Nicotine antagonists for nicotine-responsive neuropsychiatric disorders |
| 06/18/2009 | WO2009076631A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | WO2009076512A1 Carboxamidξ compounds and their use as chemokine receptor agonists |
| 06/18/2009 | WO2009076373A1 Heterocyclic kinase inhibitors |
| 06/18/2009 | WO2009076352A1 Gamma secretase modulators |
| 06/18/2009 | WO2009076166A2 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | WO2009074812A1 Antibacterial condensed thiazoles |
| 06/18/2009 | WO2009074789A1 Amido-thiophene compounds and their use as 11-beta-hsd1 inhibitors |
| 06/18/2009 | WO2009074575A2 Organic compounds |
| 06/18/2009 | WO2009074333A1 Synthesis of paliperidone |
| 06/18/2009 | WO2009074260A1 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
| 06/18/2009 | WO2009044413A8 Improved process for preparing paliperidone, novel polymorphic forms of the same and process thereof |
| 06/18/2009 | WO2009038385A3 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 06/18/2009 | WO2008057855A9 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156822 Hepatitis C Inhibitor Dipeptide Analogs |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156810 Synthesis of paliperidone |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156630 Anti-tumour polycyclic carboxamides |
| 06/18/2009 | US20090156626 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 06/18/2009 | US20090156610 Spiroindolinone Derivatives |
| 06/18/2009 | US20090156607 2-oxo-1-pyrrolidine derivatives |
| 06/18/2009 | US20090156605 Quinolones and azaquinolones that inhbit prolyl hydroxylase |
| 06/18/2009 | US20090156604 Fused bicyclic imidazoles |
| 06/18/2009 | US20090156603 2-aminopyridine analogs as glucokinase activators |
| 06/18/2009 | US20090156599 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156597 Novel Compounds |
| 06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
| 06/18/2009 | US20090156583 Tricyclic Amide Derivatives |
| 06/18/2009 | US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
| 06/18/2009 | US20090156577 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 06/18/2009 | US20090156576 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases |
| 06/18/2009 | US20090156575 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
| 06/18/2009 | US20090155787 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571 |
| 06/18/2009 | US20090155210 Oximyl hcv serine protease inhibitors |
| 06/18/2009 | US20090153041 Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same |
| 06/18/2009 | US20090153035 Heteroaromatic cycle-containing compound, method of preparing the same and organic light emitting device comprising the same |
| 06/18/2009 | DE102007059683A1 New heterocyclic annellated perylene compounds useful e.g. as pigment, preferably in printing colors and inks, in optical recording materials, organic light emitting diodes and photovoltaic cells, for decorative or artistic purposes |
| 06/18/2009 | CA2709021A1 Antibacterial condensed thiazoles |
| 06/18/2009 | CA2708364A1 Carboxamide compounds and their use as chemokine receptor agonists |
| 06/18/2009 | CA2708300A1 Gamma secretase modulators |
| 06/18/2009 | CA2708150A1 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | CA2707857A1 Organic compounds |
| 06/18/2009 | CA2707047A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/17/2009 | EP2070929A1 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 06/17/2009 | EP2070928A1 7-azaindol-3-ylacrylamides active as kinase inhibitors |
| 06/17/2009 | EP2070927A1 Fused heterocyclic derivative |
| 06/17/2009 | EP2070922A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
| 06/17/2009 | EP2070921A1 Indolylmaleimide derivatives as protein kinase c inhibitors |
| 06/17/2009 | EP2070914A1 New antagonist derivatives of the vitronectin receiver, method for preparing same, application of same as medicine and pharmaceutical compositions containing them |
| 06/17/2009 | EP2069353A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 06/17/2009 | EP2069346A1 Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof |
| 06/17/2009 | EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 06/17/2009 | EP2069344A2 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 06/17/2009 | EP2069343A2 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine |
| 06/17/2009 | EP2069342A1 2-aryl-6-phenylimidazo[1,2-alpha]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 06/17/2009 | EP2069341A1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
| 06/17/2009 | EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/17/2009 | EP1877409B1 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 06/17/2009 | EP1866306B1 Imidazopyridine derivatives useful as inos inhibitors |
| 06/17/2009 | EP1836166B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/17/2009 | EP1789419B1 Gyrase inhibitors and uses thereof |
| 06/17/2009 | EP1740591B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 06/17/2009 | EP1735320B1 Compounds and methods for treating dyslipidemia |
| 06/17/2009 | EP1664046B1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 06/17/2009 | EP1656365B1 A method for the preparation of enantiomerically pure mirtazapine |
| 06/17/2009 | EP1542990B1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 06/17/2009 | EP1485381B1 Azolylaminoazine as inhibitors of protein kinases |
| 06/17/2009 | CN101460497A Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
| 06/17/2009 | CN101460496A Mono and di-substituted oxycodone compounds and compositions |
| 06/17/2009 | CN101456858A Cyano-containing fused heterocyclic ketene aminals with chiral centre and synthetic method thereof |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/16/2009 | US7547784 For analyzing phosphorylated substances; polyamine ligand such as N,N,N',N'-tetrakis((6-methyl-2-pyridyl)methyl)-1,3-diamino-2-hydroxypropane reacted with zinc acetate |
| 06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
| 06/16/2009 | US7547707 Spirocyclic cyclohexane compounds |
| 06/16/2009 | US7547706 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 06/16/2009 | US7547695 Pyridopyrimidinones |
| 06/16/2009 | US7547694 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 06/16/2009 | US7547274 Radioactive member and method of making |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 06/11/2009 | WO2009073779A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073777A1 Gamma secretase modulators |
| 06/11/2009 | WO2009073677A1 Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes |
| 06/11/2009 | WO2009073300A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/11/2009 | WO2009071577A1 Oxadiazole derivatives and their use as nicotinic acetylcholine receptor modulators |
| 06/11/2009 | WO2009047499A3 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes |
| 06/11/2009 | WO2008060907A3 Pyrrolo-pyridine kinase inhibitors |
| 06/11/2009 | WO2008046758A3 Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes |
| 06/11/2009 | WO2006119504A3 Fused heterocyclic compounds, and compositions and uses thereof |
| 06/11/2009 | WO2005095402A9 Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds for use in the treatment of obesity |
| 06/11/2009 | US20090149495 Compounds |